_PRIVATE_LIMITED.webp)
Jainam Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.91 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 45.68 Cr
- Satisfied Charges ₹ 4.50 Cr
- Revenue Growth 62.16%
- Profit Growth 30.05%
- Ebitda 3.02%
- Net Worth 9.28%
- Total Assets 20.22%
About Jainam Pharma (India)
Jainam Pharma (India) Private Limited (JPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 June 2010 and has a history of 14 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.91 M.
The company currently has active open charges totaling ₹45.68 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sheetal Shah and Vishal Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24297MH2010PTC203695
- Company No.
203695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jainam Pharma (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheetal Shah  | Director | 04-Jun-2010 | Current |
| Vishal Shah | Director | 04-Jun-2010 | Current |
Financial Performance of Jainam Pharma (India).
Jainam Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.16% increase. The company also saw a substantial improvement in profitability, with a 30.05% increase in profit. The company's net worth moved up by a moderate rise of 9.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jainam Pharma (India)?
In 2023, Jainam Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹456.82 M
₹45.00 M
Charges Breakdown by Lending Institutions
- Others : 28.03 Cr
- Standard Chartered Bank : 17.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2024 | Standard Chartered Bank | ₹15.00 Cr | Open |
| 27 Feb 2024 | Standard Chartered Bank | ₹2.65 Cr | Open |
| 14 Dec 2021 | Others | ₹1.00 Cr | Open |
| 16 Sep 2020 | Others | ₹2.03 Cr | Open |
| 30 Aug 2013 | Others | ₹25.00 Cr | Open |
How Many Employees Work at Jainam Pharma (India)?
Jainam Pharma (India) has a workforce of 31 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jainam Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jainam Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.